ArticleJournal of experimental & clinical cancer research : CR2019

Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer.

Vivek K Kashyap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.